Related Experiment Videos

[Brain abscess secondary to rhinosinusitis. Therapeutical modalities. Exposition of one case]

L A García González1, F Redondo Ventura, L Betancor Martínez

  • 1Servicio ORL, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife. luisgarcia@comtf.es

Anales Otorrinolaringologicos Ibero-Americanos
|April 13, 2004
PubMed

Insights

Brain abscess (BA) is a rare complication of sinusitis, often caused by chronic sinus infections spreading through veins. While less common than other intracranial issues, understanding its mechanisms is crucial for patient outcomes.

Area of Science:

  • Neurology
  • Otolaryngology
  • Infectious Diseases

Background:

  • Brain abscess (BA) accounts for approximately 3% of sinusitis complications.
  • Other suppurative intracranial complications like meningitis are more frequent than BA.
  • The frontal and ethmoid sinuses are closely associated with the skull base, facilitating infection spread.

Observation:

  • Intracranial spread of sinusitis-related infections primarily occurs via thrombophlebitis of associated veins.
  • Osteitis, particularly involving the frontal sinus, represents an less common but significant route of infection.
  • Chronic sinusitis is a more frequent precursor to BA than acute sinusitis.

Findings:

  • Epidemiology of BA has shifted, with increased incidence in immunocompromised individuals and decreased incidence linked to sinus infections.
  • Historically, mortality rates for BA ranged from 35-55% before the advent of CT scanning and routine surgical excision.

Implications:

  • Understanding venous thrombophlebitis and osteitis pathways is key for preventing BA.
  • Changes in BA epidemiology necessitate updated diagnostic and treatment strategies, especially for immunocompromised patients.
  • Advances in imaging and surgical techniques have likely improved outcomes for brain abscess patients.

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: